Aging and lateralization of the rat brain on a biochemical level
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
- MeSH
- 17-hydroxysteroidní dehydrogenasy metabolismus MeSH
- Alzheimerova nemoc metabolismus MeSH
- biologické markery metabolismus MeSH
- cholin metabolismus MeSH
- citrátsynthasa metabolismus MeSH
- druhová specificita MeSH
- funkční lateralita MeSH
- krysa rodu Rattus MeSH
- lidé MeSH
- mozek metabolismus MeSH
- potkani Long-Evans MeSH
- potkani Wistar MeSH
- stárnutí metabolismus MeSH
- synthasa oxidu dusnatého, typ I metabolismus MeSH
- synthasa oxidu dusnatého, typ II metabolismus MeSH
- synthasa oxidu dusnatého, typ III metabolismus MeSH
- velký mozek metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- lidé MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
- Názvy látek
- 17-hydroxysteroidní dehydrogenasy MeSH
- biologické markery MeSH
- cholin MeSH
- citrátsynthasa MeSH
- synthasa oxidu dusnatého, typ I MeSH
- synthasa oxidu dusnatého, typ II MeSH
- synthasa oxidu dusnatého, typ III MeSH
It has been suggested that the lateralization of the human brain underlies hemispheric specialization and that it can be observed also on a biochemical level. Biochemical laterality appears to be a basis of volumetric or functional asymmetry but direct relationships among them are still unclear. Moreover, age-related differences between the right and left hemispheres are not well documented in various rat strains. In the current study, biochemical markers sensitive to Alzheimer disease (activities of high-affinity choline uptake and of nitric oxide synthases, expression of 17beta-hydroxysteroid dehydrogenase type 10) were estimated in both hemispheres of young and old male Wistar/Long Evans rats. Our experiments indicate (1) differences in some biochemical markers between young Wistar and Long Evans rats (the activities of endothelial nitric oxide synthase are higher in Long Evans and those of citrate synthase in Wistar rats), (2) more similar brain asymmetry of healthy human/young Wistar brains when compared to those of young Long Evans, (3) the decrease in asymmetry of the physiologically left/right lateralized biomarker during aging (the activity of the high-affinity choline uptake decreases more markedly in the left side of old Wistar rats) in accordance with the HAROLD model, (4) the age-related shift to reversed left/right asymmetry of the physiologically right/left lateralized biomarker (the activity of inducible nitric oxide synthase increases especially in the left side of old Long Evans rats), and finally (5) age-related differences in physiologically unlateralized biomarkers between Wistar and Long Evans rats (changes in the activities of neural/endothelial nitric oxide synthases or in expression of 17beta-hydroxysteroid dehydrogenase type 10 are more asymmetrical in old Wistar when compared to rather bilateral alterations of old Long Evans animals). It seems that the physiological lateralization of the human or rat brains on a biochemical level and their age-related alterations are dependent on biomarker type/function. By our opinion, it is difficult, perhaps impossible, to make one simple universal model, at least on a biochemical level. Since lateral analyses are of sufficient sensitivity to reveal subtle links, we recommend using Wistar rather than Long Evans rats in modeling of diseases accompanied by alterations in brain asymmetry.
Zobrazit více v PubMed
Neurosci Lett. 1984 Sep 7;50(1-3):301-5 PubMed
Neurochem Res. 2008 Jul;33(7):1216-23 PubMed
Anal Biochem. 1976 May 7;72:248-54 PubMed
Nat Rev Neurosci. 2003 Jan;4(1):37-48 PubMed
J Neurochem. 1984 Feb;42(2):351-6 PubMed
J Psychiatr Res. 2002 Jan-Feb;36(1):27-32 PubMed
Endocrinology. 2003 Jul;144(7):3130-7 PubMed
J Surg Res. 2006 Mar;131(1):64-72 PubMed
Neurochem Int. 2008 Nov;53(5):118-25 PubMed
Neurobiol Aging. 1989 Mar-Apr;10(2):143-8 PubMed
Prog Neurobiol. 2005 Jun;76(2):126-52 PubMed
Brain Res. 2002 Nov 29;956(2):385-92 PubMed
Neurochem Res. 2004 Apr;29(4):671-80 PubMed
Curr Protein Pept Sci. 2004 Dec;5(6):497-506 PubMed
Brain Res Brain Res Rev. 1999 Aug;30(2):135-52 PubMed
Brain Res. 1982 Feb 18;234(1):53-63 PubMed
Dement Geriatr Cogn Disord. 2008;26(3):193-8 PubMed
Neurosci Lett. 2004 Nov 11;370(2-3):175-9 PubMed
Behav Neurosci. 2009 Apr;123(2):276-83 PubMed
Behav Brain Res. 2002 Aug 21;134(1-2):467-77 PubMed
Brain Res Brain Res Protoc. 2001 Dec;8(3):176-83 PubMed